A1C Level and Future Risk of Diabetes: A Systematic Review
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
We examined ranges of A1C useful for identifying persons at high risk for diabetes prior to preventive intervention by conducting a systematic review. From 16 included studies, we found that annualized diabetes incidence ranged from 0.1% at A1C <5.0% to 54.1% at A1C >or=6.1%. Findings from 7 studies that examined incident diabetes across a broad range of A1C categories showed 1) risk of incident diabetes increased steeply with A1C across the range of 5.0 to 6.5%; 2) the A1C range of 6.0 to 6.5% was associated with a highly increased risk of incident diabetes, 25 to 50% incidence over 5 years; 3) the A1C range of 5.5 to 6.0% was associated with a moderately increased relative risk, 9 to 25% incidence over 5 years; and 4) the A1C range of 5.0 to 5.5% was associated with an increased incidence relative to those with A1C <5%, but the absolute incidence of diabetes was less than 9% over 5 years. Our systematic review demonstrated that A1C values between 5.5 and 6.5% were associated with a substantially increased risk for developing diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As with the glucose measures, several prospective studies that used A1C to predict the progression to diabetes as de fi ned by A1C criteria demonstrated a strong, continuous association between A1C and subsequent diabetes.”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those with an A1C range of 6.0 -6.5% (42 -48 mmol/mol) had a 5-year risk of developing diabetes between 25% and 50% and a relative risk 20 times higher than that with A1C of 5.0% (31 mmol/mol) (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that the risk of diabetes development on the basis of FPG and 2-h postload glucose is broadly similar to that posed by A1c.14,18”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to glucose measurements, the continuum of risk is continuous: as A1C rises, the diabetes risk rises disproportionately (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“In a systematic review of 44,203 individuals from 16 cohort studies with a follow-up interval averaging 5.6 years (range 2.8 -12 years), those with A1C between 5.5% and 6.0% (between 37 and 42 mmol/mol) had a substantially increased risk of diabetes (5-year incidence from 9% to 25%).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575 · cited 1×
“The progression of risk of diabetes with A1C is similar in magnitude and shape as previously described for fasting plasma glucose and 2-h glucose and suggests that A1C may have a similar application as an indicator of future risk (27).”
BackgroundRelationship between glycated haemoglobin levels and mean glucose levels over time
Nathan, D. M., Turgeon, H., & Regan, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0803-0 · Cited by 517 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
Background
Research works printed but not linked: 1
- Clarke, 2001, Cochrane Reviewers Handbook
Cited by
Items 301–400 of 422
Ledford, C. J. W., Fulleborn, S. T., Jackson, J. T., Rogers, T., & Samar, H. (2021) · Health Expectations · doi:10.1111/hex.13245 · Cited by 3
Reply to "Precision medicine in the clouds"
Magis, A. T., Earls, J. C., Glusman, G., Omenn, G. S., Lovejoy, J. C., Price, N. D., & Hood, L. (2018) · Nature Biotechnology · doi:10.1038/nbt.4211 · Cited by 3
López, A. A. P., Chávez-Negrete, A., Rodríguez-Lozano, A. L., Gómez-Alarcón, Á. J., Montaño-Velázquez, B. B., Hinojosa, C. A., Sánchez-Hernández, C., Pimentel-Hernández, C., Dehesa-López, E., Romero-Moreno, F., et al. (2023) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.m23000030 · Cited by 9
Lu, T., Stein, D., Zhang, W., Itan, Y., & Paterson, A. D. (2026) · Genetics in Medicine · doi:10.1016/j.gim.2026.101943 · Cited by 2
Diyabet Bakımında Ebeveyn İzleminin Adölesanlarda Tedaviye Uyum Ve Metabolik Parametrelere Etkisi
Avan, H. (2021) · Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi · doi:10.34087/cbusbed.765495 · Cited by 2
Association between Nighttime Work and HbA1c Levels in South Korea
Lee, Y.-S., Joo, J. H., & Park, E. (2022) · Healthcare · doi:10.3390/healthcare10101977 · Cited by 4
“27 times higher incidence of impaired fasting glucose disorder in the groups that skipped meals [36,37].”
Carter, E. W., Vadari, H. S., STOLL, S. C., Rogers, B., Resnicow, K., Heisler, M., Herman, W. H., Kim, H. M., McEwen, L. N., Volpp, K. G. M., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107038 · Cited by 2
The evolving continuum of dysglycaemia: Non‐diabetic hyperglycaemia in older adults
Golding, J. A., Hope, S. V., Chakera, A. J., & Puttanna, A. (2023) · Diabetic Medicine · doi:10.1111/dme.15177 · Cited by 3
Melakhessou, M. A., Becheker, I., Marref, S. E., Bensaad, M. S., Alyamani, A. A., Sami, R., Helal, M. M. K., Aljaadi, A. M., Al-Eisa, R. A., Algehainy, N. A., et al. (2023) · Journal of Biobased Materials and Bioenergy · doi:10.1166/jbmb.2023.2288 · Cited by 3
Jing, L., Liang, Z., Liang, Y., Cao, X., Tang, X., Zhuang, H., Yin, X., Zhao, D., & Shen, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02451-0 · Cited by 3
“Gestational diabetes mellitus (GDM) is one of the common pregnancy complications in obstetrics and is defined as a glucose intolerance resulting in hyperglycaemia of variable severity with onset or first recognition during pregnancy [1–4 ].”
Health implications of prediabetes and the role of trace elements in insulin resistance
Amer, H. M., Aboelyazed, S., Elshafeey, F., & Elhalawany, S. H. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00811-9 · Cited by 3
“%) was linked with a relative risk for diabetes of almost 20 in comparison with an HbA1 C below 5%, with a 5-year cumulative incidence of diabetes ranging from 25 to 50% [45] .”
Martínez, W. A. R., Salazar-Solarte, A. M., Sánchez-Machado, D. M., Figueroa, L., Pacheco, R., Bolaños-Moreno, Y., & Casanova, M. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00224-w · Cited by 2
Diagnostic Criteria and Classification of Diabetes
Gospin, R., & Zonszein, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-1 · Cited by 2
So kann die Diabetesflut eingedämmt werden: Screening und frühzeitige Präventionsmaßnahmen
Palitzsch, K., & Bührlen, M. (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-0586-1 · Cited by 3
Irmayanti, I., Farmawati, A., & Purba, M. B. (2019) · Gizi Indonesia · doi:10.36457/gizindo.v42i1.282 · Cited by 5
Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L. (2011) · Diabetes Care · doi:10.2337/dc10-2155 · Cited by 2
“Robinson and Abdel-Motagally (1) compared their findings from FINDRISC, an individual study, to our summary estimates from a systematic review (2) and concluded that our A1C review overestimated future diabetes incidence.”
ResultSelf-citationLaboratorydiagnosis of prediabetes
Odrowąż‐Sypniewska, G. (2016) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0009.3632 · Cited by 2
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_7 · Cited by 7
PRESENCE OF SUBCLINICAL POLYNEUROPATHY IN PATIENTS WITH ELEVATION OF HbA1c
Çetinkaya, Y., Özdemir, G., Bayır, B. R. H., & Mısırlı, C. H. (2023) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28413 · Cited by 2
Biavaschi, M. D. S., Morsch, V. M., Jacobi, L. F., Hoppen, A., Bottari, N. B., & Schetinger, M. R. C. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.05.009 · Cited by 3
Définition, classification et diagnostic du diabète, du prédiabète et du syndrome métabolique
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.405 · Cited by 2
Glycated hemoglobin, serum proteins, and other markers as tools for monitoring
Gerber, S. M., Stickle, D. F., Ahmed, I., & Jabbour, S. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch59 · Cited by 5
Robinson, C. A., & Abdel-Motagally, M. (2011) · Diabetes Care · doi:10.2337/dc10-1901 · Cited by 2
“(1) in their recent systematic review and then compare the predicted (5-year) diabetes incidence for FINDRISC versus their estimates (except for A1C , 5.”
InfluentialRole of the laboratory in diabetes diagnosis and screening—The 2013 CDA CPGs
Punthakee, Z. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.019 · Cited by 2
Bron, M., Ayyagari, R., Sharma, H., Chen, K. S., Bozas, A., & Wu, E. Q. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2755 · Cited by 1
Perreault, L. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_2 · Cited by 1
Tseng, E., Smith, K. C., Clark, J. M., Segal, J. B., Marsteller, J. A., & Maruthur, N. M. (2024) · BMJ Open Quality · doi:10.1136/bmjoq-2024-002752 · Cited by 1
Silva, J. B. Q., Cebada, A. B., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.018 · Cited by 2
Zhang, Z., Liu, C., Tan, X., Wang, J., & Yao, J. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70054 · Cited by 1
“Integrating HFG management into existing primary healthcare systems could further enhance accessibility and cost‐effectiveness [49].”
Wang, S., Yip, B. H. K., Poon, P. K.-M., Chiu, B. C. F., Wong, S. Y. S., Chan, J. C. N., & Lee, E. K. P. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112344 · Cited by 1
Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
de Oliveira, G. M. M., de Almeida, M. C. C., Valério, C. M., Giuffrida, F. M. A., Espíndola, L. N., Izar, M. C. D. O., Marques-Santos, C., Freire, C. M. V., Albuquerque, C. J. D. M., Chagas, A. C. P., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250615i · Cited by 2
Posicionamento sobre a Saúde Cardiometabólica ao Longo do Ciclo de Vida da Mulher – 2025
de Oliveira, G. M. M., de Almeida, M. C. C., Valério, C. M., Giuffrida, F. M. A., Espíndola, L. N., Izar, M. C. D. O., Marques-Santos, C., Freire, C. M. V., Albuquerque, C. J. D. M., Chagas, A. C. P., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250615 · Cited by 5
Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
de Oliveira, G. M. M., de Almeida, M. C. C., Valério, C. M., Giuffrida, F. M. A., Espíndola, L. N., Izar, M. C. D. O., Marques-Santos, C., Freire, C. M. V., Albuquerque, C. J. D. M., Chagas, A. C. P., et al. (2025) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2025rbgo200 · Cited by 2
Prediabetes before pregnancy: implications for risk stratification and research
Bhattacharya, S., Mohan, V., Nagendra, L., & Saravanan, P. (2026) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000964 · Cited by 1
Wei, C., Cao, C., Zengxin, X., Chen, G., Liu, W., Zhang, M., Hu, H., & Xu, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350633 · Cited by 1
“…cohort that followed more than 30,000 individuals, for example, used multivariable modelling to show that even triglyceride concentrations remaining within the conventionally accepted reference interval were remained an independent predictor of heightened diabetes risk over follow-up [25,26].”
Impact of Implementing Glycated Hemoglobin Testing for Identification of Dysglycemia in Youth
Vijayadeva, V., & Nichols, G. A. (2014) · The Permanente Journal · doi:10.7812/tpp/14-029 · Cited by 1
Improving the Undiagnosed Rate of Diabetes Mellitus Using a Point-of-Care A1C Device
Whitley, H. P. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00025 · Cited by 1
“Therefore, the average patient screened in this study whose HbA1c was below the diagnostic limit has a 9-25% relative risk of developing type 2 diabetes in 5 years [18,21].”
BackgroundSkeletal Muscle Impairments in People with Diabetes and Peripheral Neuropathy
Tuttle, L. J. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k75q4t65 · Cited by 2
The importance of prediabetes and therapeutic approach
Altuntaş, Y., & Öztürk, F. Y. (2015) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.5350/semb.20151126122000 · Cited by 5
Dietary Management of Pre-Diabetes and Type 2 Diabetes
Ajala, O., & English, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00007-7 · Cited by 4
Mv, L. (2017) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2017.04.00103 · Cited by 1
“To our knowledge, this is the first report that compares the relationship of A1C levels with the results of OGTT and FPG on a group of Brazilian subjects with IFG that willingly presented to an endocrinologic check-up.”
InfluentialHbA1c Evidence for a Prediabetes Diagnosis Delays Onset of Type 2 Diabetes
Johnson, M. C., Fishbein, H. A., Birch, R. J., Yu, Q., Mardon, R., Pace, W. D., Ritchie, N. D., Carroll, J. K., & Meeker, D. (2021) · Journal of Endocrinological Science · doi:10.29245/2767-5157/2021/1.1114 · Cited by 3
Fonkoua, M., Ze, M. Z., Tazon, W. A., Youovop, J. A. F., Takuissu, G. R., & Ngondi, J. L. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100203 · Cited by 1
ŞANİBAŞ, A. V., Çakmak, F., BAYDAR, İ., & BİNİCİ, D. N. (2023) · New Trends in Medicine Sciences · doi:10.56766/ntms.1161735 · Cited by 1
Lin, H., Wang, J., Tseng, P.-Y., Fu, L., Lee, Y., Wu, M., Yang, W., & Chiu, H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110567 · Cited by 2
Beckwitt, C. H., Schulz, W., Carrozzi, S., Wera, J. C., Wasil, K., & Fowler, J. R. (2023) · Journal of Hand and Microsurgery · doi:10.1055/s-0043-1764163 · Cited by 1
Cost-effectiveness of treatment intervention in prediabetic patients in Bulgaria
Yordanova, S., Mitov, K., & Kamusheva, M. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e110104 · Cited by 2
Development and validation of gestational diabetes mellitus health literacy scale
Gu, R., Sun, T., Pan, Y., Wang, J., Li, Q., Zhang, Y., Tang, Y., Zhou, H., & Wei, L. S. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108365 · Cited by 1
The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice
Yu, T., Shang, N., Chen, L., Lü, K., Xia, H., Yang, L., Wang, S., Sun, G., & Liao, W. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70178 · Cited by 3
Diabetes mellitus: An overview
Sonia, T. A., & Sharma, C. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30272-5.00007-x · Cited by 1
Diabetes and the Cardiovascular System
Cohen, P., & Plutzky, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_41 · Cited by 1
Sari, P. W. A., & Isnawati, M. (2014) · Journal of Nutrition College · doi:10.14710/jnc.v3i1.4529 · Cited by 4
Al-Mutairi, G. F., Abdul-Halim, I. M., Albawi, A. A., & El-Shazly, M. K. (2013) · Greener Journal of Medical Sciences · doi:10.15580/gjms.2013.2.012013399 · Cited by 1
“(World Health Sciences 2010) Currently, glycosylated hemoglobin (A1C) is widely accepted as a measure of glycemic control in established diabetes, an indicator of the risk for development of diabetic complications, and a reflection of the quality of diabetes care (Zhang et al., 2010).”
Johnson, K. L. (2016) · UKnowledge (University of Kentucky) · Cited by 1
Gann, D. (2016) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2016.03.00089 · Cited by 1
Ali Khalaf Hasan1, S. H. A. (2020) · Medico-Legal Update · doi:10.37506/mlu.v20i4.1966 · Cited by 1
Romeo, G. R., Silva, P. S., & Cavallerano, J. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_294 · Cited by 1
Identification of Those at Risk for Diabetes Mellitus
Geba, D., & Pearson, T. A. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.10.011 · Cited by 3
Is Prediabetes a Risk Factor or is it a Disease?
Muthusamy, K., & Vella, A. V. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch1
Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus
Chow, E. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
How to screen for diabetes risk in multi-ethnic populations: does one method fit all?
Schwarz, P. E. H., & Müller, G. (2013) · European Diabetes Nursing · doi:10.1002/edn.229
Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges
Aroda, V. R., & Getaneh, A. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1054280
“The risk of developing T2DM is fivefold to sixfold for individuals with this phase of prediabetes [11–15], and even higher in some studies [13,14], without a distinct cut-point for fasting plasma glucose (FPG) [16] or hemoglobin A1c (HbA1c) [15,17,18].”
BackgroundBhandarkar, P. V. (2012) · California State University ScholarWorks (system-wide DSpace)
Diagnosi di diabete: è sufficiente l'HbA1c?
Cosma, C. (2013) · Padua Research Archive (University of Padova)
Síndrome metabólico en niños: problemática, componentes y criterios diagnósticos
de Antioquia, U., Marín-Echeverri, C., Arias, A. A., de Antioquia, U., Gallego-Lopera, N., Bolivariana, U. P., Barona-Acevedo, J., & de Antioquia, U. (2015) · Perspectivas en Nutrición Humana · doi:10.17533/udea.penh.v17n2a06
Pre-diabetes Screening Tools for Adults Living in the United States
Evans, E. (2014) · Digital Commons @ UNT Health Science Center
Diabetes tipo 2: Avaliação do risco, prevenção, controle e influência do exercíciofísico regular
de Moura, B. P. (2011) · Americanae (AECID Library) · Cited by 1
HbA1c5.6~6.4%かつFPG100~125mg/dLの糖尿病前症は糖尿病発症の高リスク群
亀谷, 富., 坪野由美, 久子, 小., 千佳子, 佐., 沙也可, 橋., 沙保里, 若., 麻樹子, 山., & 澁谷直美 (2017) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.32.544
11th Annual Symposium on Self-Monitoring of Blood Glucose: April 12–14, 2018, Oslo, Norway
Parkin, C. G., Homberg, A., & Hinzmann, R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0284
Prediabetes: An Update and a Rational for Diagnostic Confusion
Bakıner, O., Bozkırlı, E., Aksöyek, A., & Özşahin, A. K. (2019) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.528045
“5 have 25-50% risk for progression to diabetes for 5 years.((16-17)) In the Whitehall study released in 2009; duration between the start of metabolic disorders and overt diabetes was shown to be 13 years and that no glycemic abnormalities were detected in blood 2-6 years before the onset of diabetes and also this dura…”
BackgroundArnold, M. J. (2018) · Evidence-Based Practice · doi:10.1097/ebp.0000000000000065
Tg, S., Bhargavi, S. K., Kalaburgi, R. A., Hk, S., Kavitha, B. S., & Arifuddin, M. K. (2020) · Scholars International Journal of Biochemistry · doi:10.36348/sijb.2020.v03i06.001 · Cited by 1
“5% pose a 5-year risk of 25% to 50% of developing DM which can be critically intervened by early identification of patients with preDM[14].”
BackgroundMohan, M. (2019) · Discovery Research Portal (University of Dundee)
Understanding Diabetes Mellitus
Phillips, A., & Gadsby, R. (2012) · doi:10.1093/oso/9780199697410.003.0019
Matabuena, M., Félix, P., Meijide-Garcia, C., & Gudé, F. (2020) · arXiv (Cornell University) · doi:10.13140/rg.2.2.14674.99529 · Cited by 1
CORRELATION BETWEEN SERUM URIC ACID IN PRE DIABETICS AND DIABETICS:A PROSPECTIVE OBSERVATIONAL STUDY
Gupta, A., GUPTA, J., & SANGHAVI, S. T. (2020) · British Journal of Medical and Health Research · doi:10.46624/bjmhr.2020.v7.i12.001
So kann die Diabetesflut eingedämmt werden: Screening und frühzeitige Präventionsmaßnahmen
Palitzsch, K., & Bührlen, M. (2012) · MMW - Fortschritte der Medizin
КРИТЕРИИ ДИАГНОСТИКИ ПРЕДИАБЕТА У ДЕТЕЙ И ПОДРОСТКОВ С ОЖИРЕНИЕМ: ОБЗОР ЛИТЕРАТУРЫ
Толстикова, Е. (2018) · Научный взгляд в будущее · doi:10.30888/2415-7538.2021-22-01-032
“Is Prediabetes a Risk Factor or Is It a Disease?”
Kohlenberg, J. D., & Vella, A. V. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch1
Romeo, G. R., Silva, P. S., & Cavallerano, J. D. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_294-1
Bailey-Davis, L. D., Wood, G. C., McCabe, C. F., Cook, A., Rolston, D. D. K., Seiler, C. J., & Still, C. D. (2022) · medRxiv · doi:10.1101/2022.06.07.22274277
Diabetes Prevention at Work: 10-Year Results of Health Coaching and Monetary Incentives
Raymond, L. W. (2022) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002535
Pre-diabetes: Diagnostic Criteria And Therapeutic Approach
Chowdhury, S. R. (2019) · Journal of Chittagong Medical College Teachers Association · doi:10.3329/jcmcta.v29i2.62537
Eriş, D. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2576
Sagar, B. (2023) · Digital Repository Service (Northeastern University) · doi:10.17760/d20531819
Role of newer anti-diabetes drugs in prediabetes: A systematic review
Singh, A. K., & Singh, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00037-2
Multi-label residual weighted learning for individualized combination treatment rule
Xu, Q., Cao, X., Chen, G., Zeng, H., Fu, H., & Qu, A. (2024) · Electronic Journal of Statistics · doi:10.1214/24-ejs2236
“Since some combination treatments were assigned to fewer than 10 subjects, we perform stratified sampling to ensure that the training set includes all possible combination treatments.”
BackgroundRahmania, S., Bhargav, H., & Basu‐Ray, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99645-7.00006-8
Ali, S. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch01
Njike, V. Y., Ayettey, R. G., Treu, J. A., Comerford, B. P., & Onuigbo, M. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101448
“HbA1c levels predict future risk for T2DM [23].”
Nwanaji‐Enwerem, J. C., Espinosa, P. R., Khodasevich, D., Gladish, N., Shen, H., Bozack, A. K., Daredia, S., Needham, B. L., Rehkopf, D. H., & Cárdenas, A. (2025) · Epigenomics · doi:10.1080/17501911.2025.2476378 · Cited by 2
Optimum Fasting Plasma Glucose Cut Points to Screen Diabetes in China
Gong, Y., Tan, H., Yang, Y., Qu, Y., Yang, Q., & Zhou, J. C. (2024) · International Conference on Public Health and Data Science (ICPHDS) · doi:10.1145/3718677.3718711
Albdour, M. M., El‐Masri, M. M., Jaber, L. A., Burghardt, P. R., Jenuwine, E., & Lumley, M. A. (2025) · Canadian Journal of Nursing Research · doi:10.1177/08445621251332166
“One important implication of the current study is that addressing chronic stress using EAET may provide people with pre-diabetes with a new tool to prevent the progression of prediabetes to T2D.”
InfluentialBowen, M. E., Fish, J., Bhat, D., Kim, E. S., Zhang, S., & Halm, E. A. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09543-1
Racek, J., Růžičková, V., & Rajdl, D. (2011) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2011.022
Lu, T., Stein, D., Zhang, W., Itan, Y., & Paterson, A. D. (2025) · medRxiv · doi:10.1101/2025.07.17.25331703
High-intensity functional training and metabolic health
Oh, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30014-1.00011-6
Prediabetes in metabolic syndrome
Babenko, A. Y. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6538 · Cited by 1
Metadata
- Authors
- Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Corresponding author
- Zhang, Xuanping
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-07-01
- Volume
- 33
- Issue
- 7
- Pages
- 1665-1673
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890379
- OpenAlex
- W2137837290
- Cited by
- 422
- References
- 32
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 30 · 2023: 34 · 2022: 28 · 2021: 34 · 2020: 22 · 2019: 22 · 2018: 22 · 2017: 27 · 2016: 27 · 2015: 29 · 2014: 26 · 2013: 29 · 2012: 24
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- HbA1c, new-onset diabetes, diabetes risk prediction, prediabetes, diabetes prevention, HbA1c thresholds, diabetes incidence
- MeSH terms
- Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

